← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Expression Genetics, Inc.
Huntsville, AL
$2,141,341
Total funding
3
Grants
Funding over time
peak $513.7K · FY2007–13$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
FDA$1,977,628 · 2
NIH$163,713 · 1
By mechanism
R01$1,977,628 · 2
R43$163,713 · 1
Investigators at Expression Genetics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Phase 2 of EGEN-001 for Tx of Chemotherapy-Resistant Recurrent Ovarian Cancer$400,000
R01 · FY2011 · FD
Phase 2 of EGEN-001 for Tx of Chemotherapy-Resistant Recurrent Ovarian Cancer$400,000
R01 · FY2012 · FD
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER$350,000
R01 · FY2007 · FD
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER$350,000
R01 · FY2008 · FD
PHASE I/II STUDIES OF EGEN-001 THERAPY FOR OVARIAN CANCER$350,000
R01 · FY2009 · FD
Novel Combination Treatments For Brain Tumors$163,713
R43 · FY2007 · CA
Phase 2 of EGEN-001 for Tx of Chemotherapy-Resistant Recurrent Ovarian Cancer$127,628
R01 · FY2013 · FD